Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Virios Therapeutics Q2 EPS $(0.51) Beats $(0.57) Estimate

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.57) by 10.53 percent.

byBenzinga Newsdesk

August 12, 2021

1 minute read

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.57) by 10.53 percent.